But when you stuck to them, nothing much happened
If you have a Health Savings Account or Flexible Spending Account, prescription semaglutide qualifies for tax-advantaged spending
What This Means for Patients For individuals with both type 2 diabetes and CKD, Ozempic offers an important new treatment option to help protect kidney function and reduce cardiovascular risks
This effect may be more pronounced with tirzepatide than semaglutide due to the dual receptor activation
This review aims to synthesise the evidence highlighting the benefits of semaglutide in people with CKD, including those with and without T2D
Key highlights GLP-1 medications such as Ozempic, Wegovy, and Mounjaro can cost $800-$1,300 per month without insurance coverage, making them unaffordable for many patients